Metabolic Syndrome in Patients With Ankylosing Spondylitis

Basit Öğe Kaydı
dc.authoridNAS, Kemal/0000-0002-5845-0851
dc.contributor.authorBatmaz, Ibrahim
dc.contributor.authorKarakoc, Mehmet
dc.contributor.authorSariyildiz, Mustafa Akif
dc.contributor.authorYazici, Selma
dc.contributor.authorTahtasiz, Mehmet
dc.contributor.authorAtilgan, Zuhal
dc.contributor.authorCevik, Remzi
dc.date.accessioned2024-09-25T19:56:20Z
dc.date.available2024-09-25T19:56:20Z
dc.date.issued2011
dc.departmentAbant İzzet Baysal Üniversitesien_US
dc.description.abstractBackground: The objective of this study is to investigate the presence of metabolic syndrome (MS) in patients with ankylosing spondylitis (AS) and to evaluate its relationship with the clinical parameters. Methods: Fifty patients who presented to the Dicle University School of Medicine, Physical Therapy and Rehabilitation Outpatient Clinic and were diagnosed with AS according to the 1984 New York criteria were enrolled in this study. The control group consisted of 44 healthy control subjects. Assessment of the MS was made according to the diagnostic criteria specified in the National Cholesterol Education Program Adult Treatment Panel III Report (NCEP ATP III). Functional status and disease activity were evaluated using the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for AS. Results: MS was observed in 6 out of the 50 AS patients (12%) and in 2 out of the 44 controls (4.5%) (P > 0.05). However, the HDL cholesterol level (P = 0.006) was found as significantly lower in AS patients than the controls. No statistically significant differences were observed in the disease duration and functional and clinical activity indices between the AS patients with and without MS. Conclusions: Although the frequency of MS was observed to be higher in patients with AS than the controls in this study, the differences were statistically insignificant between the two groups.en_US
dc.identifier.doi10.4021/jem61e
dc.identifier.endpage219en_US
dc.identifier.issn1923-2861
dc.identifier.issn1923-287X
dc.identifier.issue5en_US
dc.identifier.startpage215en_US
dc.identifier.urihttps://doi.org/10.4021/jem61e
dc.identifier.urihttps://hdl.handle.net/20.500.12491/13232
dc.identifier.volume1en_US
dc.identifier.wosWOS:000215858000003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorNas, Kemal
dc.language.isoenen_US
dc.publisherElmer Press Incen_US
dc.relation.ispartofJournal of Endocrinology And Metabolismen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzYK_20240925en_US
dc.subjectAnkylosing spondylitisen_US
dc.subjectMetabolic syndromeen_US
dc.titleMetabolic Syndrome in Patients With Ankylosing Spondylitisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu